The global substance abuse treatment market size was valued at USD 12.58 billion in 2025 and is projected to grow from USD 13.61 billion in 2026 to USD 25.57 billion by 2034, registering a CAGR of 8.2% during the forecast period from 2026 to 2034. North America dominated the substance abuse treatment market with a market share of 41.2% in 2025.
Substance abuse treatment involves a range of medical, psychological, and behavioral therapies designed to help individuals overcome dependence on alcohol, prescription medications, and illicit drugs. These treatment programs may include detoxification, counseling, medication-assisted treatment, rehabilitation, and ongoing support to promote long-term recovery. Substance abuse treatment aims to improve physical and mental health, reduce the risk of relapse, and help individuals regain a healthier and more productive life.
Download a Free Sample To learn more about this report,
Growing Adoption of Long-Acting Injectable Treatments for Opioid Use Disorder
The substance abuse treatment market is increasingly shifting toward long-acting injectable medications that can reduce the need for daily dosing in opioid use disorder treatment. Monthly formulations can help maintain consistent therapeutic exposure while reducing challenges related to missed doses, medication storage, and daily treatment routines. This approach can also support continuity of care for patients who struggle with adherence to conventional medication schedules. The growing acceptance of extended-duration pharmacotherapy is therefore becoming an important part of substance abuse treatment market trends.
In February 2026, Indivior reported that more than 475,000 patients had been treated with SUBLOCADE, its once-monthly injectable treatment for moderate-to-severe opioid use disorder. The company also reported approximately USD 1.2 billion in total revenue for 2025, reflecting the expanding commercial adoption of long-acting addiction treatment.
Increasing Integration of Mental Health and Substance Use Treatment
Treatment providers are increasingly combining addiction services with mental health care because many individuals seeking substance use treatment also experience depression, anxiety, trauma, or other psychiatric conditions. Treating these conditions through separate programs can fragment care and make recovery more difficult. Integrated models instead coordinate behavioral health assessment, therapy, addiction treatment, and recovery planning within the same care pathway. This transition is broadening the substance abuse treatment industry toward comprehensive programs designed around co-occurring conditions rather than substance use alone.
In April 2025, Hazelden Betty Ford Foundation launched an expanded model of care integrating mental health and substance use treatment across all levels of care. The model was implemented across its 15 locations as well as its virtual-care services.
Increasing Public Funding for Addiction Treatment and Recovery Services
Greater public investment is expanding the financial resources available for addiction treatment, recovery support, crisis intervention, and related behavioral health services. Funding programs can help providers increase treatment capacity, reach underserved populations, and introduce evidence-based services that may otherwise be difficult to finance. Such investment is particularly important for individuals facing both addiction and housing or social instability, where treatment often requires coordinated support beyond medication alone. Continued funding expansion is therefore strengthening substance abuse treatment market demand across community and institutional care settings.
In February 2026, the Department of Health and Human Services announced a USD 100 million investment through the STREETS Initiative to expand addiction treatment, psychiatric care, medical stabilization, crisis intervention, outreach, and recovery-focused support.
Limited Treatment Capacity Restricts Access to Residential Care
Insufficient availability of treatment beds can prevent people with substance use disorders from entering structured care when they are ready to begin recovery. Residential and detoxification programs require trained clinicians, suitable facilities, licensing, and continuous patient supervision, making capacity more difficult to expand than standard outpatient services. Long travel distances and limited local availability can further delay treatment. These capacity constraints can restrain substance abuse treatment market growth by leaving part of the potential patient population without timely access to appropriate services.
In February 2026, Ascension Recovery Services partnered with LifeSpring Recovery to launch an 80-bed detoxification and residential substance use disorder treatment center, highlighting the need for additional inpatient treatment capacity in areas experiencing behavioral health access gaps.
Development of Novel Treatments for Alcohol Use Disorder
Alcohol use disorder represents an important opportunity for pharmaceutical developers because existing treatments do not provide satisfactory outcomes for every patient. Companies are investigating new mechanisms that could reduce alcohol consumption, cravings, and relapse while potentially offering faster or more durable therapeutic effects. Successful clinical development would expand the range of pharmacological choices available alongside behavioral interventions. Innovation in alcohol dependence therapy can therefore create new substance abuse treatment market share opportunities for companies developing differentiated medicines.
In January 2025, atai Life Sciences reported Phase 2a results for BPL-003 in 12 patients with moderate-to-severe alcohol use disorder. Following a single dose combined with relapse-prevention therapy, 50% of patients maintained complete abstinence through three months, with no serious or severe adverse events reported.
Building a Sustainable Addiction Treatment and Recovery Workforce
Treatment expansion depends on sufficient numbers of counselors, behavioral health professionals, peer-support specialists, case managers, and other trained workers. Workforce shortages can limit the number of patients providers are able to serve even when facilities and treatment programs are available. Recovery can also require employment and social reintegration support, increasing the range of professionals needed beyond direct clinical treatment. Developing and retaining this workforce therefore remains a major challenge as substance abuse treatment market size expands.
In June 2026, the Substance Abuse and Mental Health Services Administration announced USD 10.5 million in anticipated funding for its Treatment, Recovery, and Workforce Support program. The initiative is expected to provide 21 awards of up to USD 500,000 each to organizations supporting treatment, recovery, independent living, and workforce participation.
Alcohol Abuse Treatment Segment Dominated the Market with 34.7% Share in 2025
The alcohol abuse treatment segment dominated the global substance abuse treatment market with a 34.7% market share in 2025, valued at USD 4.37 billion. The segment's dominance is driven by the high global prevalence of alcohol use disorder, increasing awareness of addiction treatment, expanding rehabilitation services, and growing government initiatives to improve access to treatment programs.
The tobacco/nicotine abuse treatment, drug abuse treatment, and other segments continue to witness steady growth as awareness of substance dependence increases and healthcare providers expand treatment options. Advancements in behavioral therapies, medications, and rehabilitation programs are supporting improved recovery outcomes across these treatment areas.
Request Customizationto receive a tailored report.
The medication segment is Projected to Register the Fastest Growth at a CAGR of 8.91%
The medication segment is projected to register the fastest growth at a CAGR of 8.91% during the forecast period. Increasing adoption of medication-assisted treatment (MAT), growing availability of FDA-approved therapies, and rising focus on evidence-based addiction management are driving the rapid growth of this segment.
The detoxification, counseling and behavioral therapy, support group, and other segments continue to play a vital role in comprehensive substance abuse treatment. Growing emphasis on integrated care, personalized treatment plans, and long-term recovery support is encouraging the adoption of multiple therapeutic approaches to improve patient outcomes.
Speak to an Analystto discuss market opportunities.
The North American substance abuse treatment market accounted for 41.2% of the global market, reaching USD 5.18 billion in 2025, and is projected to grow at a CAGR of 8.11% during the forecast period. Market growth is driven by the rising prevalence of substance use disorders, increasing government funding for addiction treatment, expanding access to behavioral healthcare services, and growing adoption of medication-assisted treatment and digital recovery programs.
The United States is the largest contributor to the North American market. Rising opioid and alcohol addiction cases, increasing investments in behavioral healthcare, expanding rehabilitation facilities, and growing adoption of evidence-based treatment programs continue to drive market growth.
Growing government support for addiction recovery services, increasing awareness of mental health and substance abuse, expanding access to community-based treatment programs, and rising demand for integrated behavioral healthcare continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
The European substance abuse treatment market accounted for 27.4% of the global market, reaching USD 3.45 billion in 2025, and is expected to register a CAGR of 7.86% during the forecast period. Increasing public health initiatives, expanding mental healthcare infrastructure, growing awareness of addiction treatment, and rising adoption of comprehensive rehabilitation programs continue to support regional market growth.
Growing investments in mental health services, increasing access to rehabilitation centers, expanding community-based addiction treatment programs, and rising awareness of substance use disorders continue to strengthen market demand.
Strong healthcare infrastructure, increasing availability of evidence-based addiction therapies, expanding behavioral health services, and growing government initiatives to improve recovery outcomes continue to support market expansion.
The Asia Pacific substance abuse treatment market accounted for 19.6% of the global market, reaching USD 2.47 billion in 2025, and is projected to register a CAGR of 9.74% during the forecast period. Rising awareness of addiction and mental health, increasing healthcare investments, expanding rehabilitation facilities, growing government support for treatment programs, and improving access to behavioral healthcare continue to accelerate regional market growth.
Increasing focus on mental health awareness, expanding rehabilitation services, growing adoption of evidence-based treatment approaches, and rising healthcare investments continue to support market growth.
China represents the largest share within the Asia Pacific market. Expanding behavioral healthcare infrastructure, increasing government initiatives to address substance abuse, growing awareness of addiction treatment, and rising investments in rehabilitation services continue to drive market expansion.
Latin America's substance abuse treatment market accounted for 6.8% of the global market, reaching USD 0.86 billion in 2025, and is expected to grow at a CAGR of 8.36% during the forecast period. Increasing public awareness of addiction recovery, expanding behavioral healthcare services, growing investments in rehabilitation facilities, and rising government support for treatment programs continue to support regional market growth.
Growing investments in mental healthcare, expanding addiction rehabilitation centers, increasing access to counseling services, and rising awareness of substance use disorders continue to create long-term growth opportunities.
The Middle East & Africa substance abuse treatment market accounted for 5.0% of the global market, reaching USD 0.63 billion in 2025, and is anticipated to grow at a CAGR of 7.91% during the forecast period. Increasing investments in healthcare infrastructure, expanding mental health services, growing awareness of addiction treatment, and rising government initiatives to improve access to rehabilitation programs continue to support regional expansion.
Government initiatives to strengthen mental healthcare services, expanding rehabilitation facilities, increasing public awareness campaigns, and rising adoption of integrated addiction treatment programs continue to drive market growth.
Growing investments in behavioral healthcare, expanding access to rehabilitation services, increasing awareness of substance use disorders, and rising government support for addiction recovery programs continue to support steady market expansion.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
Facial Fat Transfer Market Size, Share, Growth, Analysis, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Medical Equipment Rental Market Size, Share, Growth, 2034
Pharmaceutical Stability and Storage Services Market Size, 2034
We are featured on:
sales@straitsresearch.com